Evidence map›Paper›PMID 41203843›Full record

ArticleScientific reports2025

Prevalence and health checkup-based detection of metabolic dysfunction-associated steatotic liver disease in Japanese young adults.

Satoko Tajirika, Takao Miwa, Tatsunori Hanai, Masahito Shimizu, Mayumi Yamamoto

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Satoko TajirikaHealth Administration Center, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan.
Takao MiwaHealth Administration Center, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan. miwa.takao.a6@f.gifu-u.ac.jp.
Tatsunori HanaiDepartment of Gastroenterology/Internal Medicine, Graduate School of Medicine, Gifu University, Gifu, Japan.
Masahito ShimizuDepartment of Gastroenterology/Internal Medicine, Graduate School of Medicine, Gifu University, Gifu, Japan.
Mayumi YamamotoHealth Administration Center, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan.

Funding

Japan Society for the Promotion of Science JP22K11774
6 · The paper itself

Abstract

We aimed to elucidate the prevalence of steatotic liver disease (SLD) in Japanese young adults and to identify health checkup-based markers for metabolic dysfunction-associated steatotic liver disease (MASLD). We recruited participants (18–29 years) attending a health checkup. Abdominal ultrasonography and health checkup data were used to diagnose and classify SLD. The diagnostic ability of serum alanine aminotransferase (ALT), fatty liver index (FLI), and hepatic steatosis index (HSI) were evaluated using receiver operating characteristic curve analysis. Among the 1632 participants in 2023, 1004 (62%) were male, and SLD was observed in 271 (17%). In the SLD subclass, 143 (9%), 1 (< 1%), 0 (0%), and 127 (8%) were diagnosed with MASLD, MASLD with moderate alcohol intake, alcohol-associated/related liver disease, and cryptogenic SLD, respectively. The area under the curve of ALT, FLI, and HSI to identify MASLD were 0.76, 0.85, and 0.84, respectively. The cutoff value of ALT to rule in (specificity 0.90) MASLD was 31 IU/L. Similar results were observed in 1743 participants in 2024. In conclusion, the prevalence of SLD and MASLD in Japanese young adults was 17% and 9%, respectively. ALT > 30 IU/L was identified as a reasonable cutoff value to identify MASLD in Japanese young adults.

Indexed as

Fatty LiverAdolescentAdultAlanine TransaminaseBiomarkersEast Asian PeopleFemaleHumansJapanMalePhysical ExaminationPrevalenceROC CurveUltrasonographyYoung AdultAlanine TransaminaseBiomarkersMetabolic dysfunction-associated steatotic liver diseaseMetALDNara DeclarationSteatotic liver diseaseYoung adult

Identifiers

PMID41203843
PMCPMC12594945

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.